Gelteq Ltd. Files 2024 Annual Report

TL;DR

Gelteq Ltd. filed its 2024 20-F, covering fiscal year ending June 30. Check it out.

AI Summary

Gelteq Ltd. filed its annual report on Form 20-F for the fiscal year ended June 30, 2024. The company, previously known as Gelteq Pty Ltd. until March 28, 2022, is incorporated in Australia and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located at Level 4, 100 Albert Road, South Melbourne, VIC 3025, Australia.

Why It Matters

This filing provides investors and the public with a comprehensive overview of Gelteq Ltd.'s financial performance and business operations for the past fiscal year, crucial for understanding the company's current standing and future prospects.

Risk Assessment

Risk Level: low — This is a standard annual report filing (20-F) and does not contain new material events or significant financial disclosures that would indicate a change in risk.

Key Numbers

• 20240630 — Fiscal Year End (The period covered by the annual report.)
• 001-42373 — SEC File Number (Identifies the company's filings with the SEC.)

Key Players & Entities

• Gelteq Ltd (company) — Registrant
• Gelteq Pty Ltd. (company) — Former company name
• 20240630 (date) — Fiscal year end
• 20220328 (date) — Date of name change
• 001-42373 (company) — SEC file number
• Level 4 100 Albert Road South Melbourne VIC , 3025 Australia (address) — Business and mailing address

FAQ

Key Financial Figures

• $3,572,900 — losses in the past of approximately AUD$3,572,900 and AUD$3,506,220 in the fiscal years e
• $3,506,220 — t of approximately AUD$3,572,900 and AUD$3,506,220 in the fiscal years ended June 30, 2024

Filing Documents

• ea0220589-20f_gelteq.htm (20-F) — 2353KB
• ea022058901ex2-1_gelteq.htm (EX-2.1) — 82KB
• ea022058901ex11-2_gelteq.htm (EX-11.2) — 71KB
• ea022058901ex12-1_gelteq.htm (EX-12.1) — 9KB
• ea022058901ex12-2_gelteq.htm (EX-12.2) — 9KB
• ea022058901ex13-1_gelteq.htm (EX-13.1) — 3KB
• ea022058901ex13-2_gelteq.htm (EX-13.2) — 3KB
• ea022058901ex97_gelteq.htm (EX-97) — 21KB
• image_001.jpg (GRAPHIC) — 18KB
• image_002.jpg (GRAPHIC) — 17KB
• image_003.jpg (GRAPHIC) — 6KB
• fin_001.jpg (GRAPHIC) — 7KB
• fin_002.jpg (GRAPHIC) — 3KB
• fin_003.jpg (GRAPHIC) — 10KB
• fin_004.jpg (GRAPHIC) — 10KB
• fin_005.jpg (GRAPHIC) — 5KB
• 0001213900-24-099131.txt ( ) — 10719KB
• gels-20240630.xsd (EX-101.SCH) — 153KB
• gels-20240630_cal.xml (EX-101.CAL) — 63KB
• gels-20240630_def.xml (EX-101.DEF) — 435KB
• gels-20240630_lab.xml (EX-101.LAB) — 837KB
• gels-20240630_pre.xml (EX-101.PRE) — 456KB
• ea0220589-20f_gelteq_htm.xml (XML) — 1504KB

FORWARD LOOKING STATEMENTS

FORWARD LOOKING STATEMENTS ii PART I 1 Item 1. Identity of Directors, Senior Management and Advisers 1 Item 2. Offer Statistics and Expected Timetable 1 Item 3. Key Information 1 Item 3A. [Reserved] 1 Item 4. Information on the Company 29 Item 4A. Unresolved Staff Comments 29 Item 5. Operating and Financial Review and Prospects 55 Item 6. Directors, Senior Management and Employees 79 Item 7. Major Shareholders and Related Party Transactions 88 Item 8. Financial Information 89 Item 9. The Offer and Listing 89 Item 10. Additional Information 90 Item 11. Quantitative and Qualitative Disclosures about Market Risk 101 Item 12.

Description Of Securities

Description Of Securities Other Than Equity Securities 102 PART II 103 Item 13. Defaults, Dividend Arrearages and Delinquencies 103 Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds 103 Item 15.

Controls and Procedures

Controls and Procedures 103 Item 16. [Reserved] 104 Item 16A. Audit Committee Financial Expert 104 Item 16B. Code of Ethics 104 Item 16C. Principal Accountant Fees and Services 105 Item 16D. Exemptions from The Listing Standards for Audit Committees 105 Item 16E. Purchases of Equity Securities by The Issuer and Affiliated Purchasers 105 Item 16F. Change in Registrant's Certifying Accountant 105 Item 16G. Corporate Governance 106 Item 16H. Mine Safety Disclosure 106 Item 16I Disclosure regarding Foreign Jurisdictions that Prevent Inspections 106 Item 16J Insider Trading Policies 106 Item 16K Cybersecurity 106 PART III 107 Item 17.

Financial Statements

Financial Statements 107 Item 18.

Financial Statements

Financial Statements 107 Item 19. Exhibits 107 i FORWARD-LOOKING This Annual Report contains "forward-looking statements" for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that represent our beliefs, projections and predictions about future events. All statements other than items, any statements of the plans, strategies and objectives of management for future operations, any statements concerning proposed new projects or other developments, any statements regarding future economic conditions or performance, any statements of management's beliefs, goals, strategies, intentions and objectives, and any statements of assumptions underlying any of the foregoing. Words such as "may," "will," "should," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions, as well as statements in the future tense, identify forward-looking These

forward-looking statements include statements relating to

forward-looking statements include statements relating to: our strategies and objectives; our ability to meet the Nasdaq requirements; our other financial operating objectives; the availability of qualified employees for business operations; general business and economic conditions; our ability to meet its financial obligations as they become due; the positive cash flows and financial viability of our operations and new business opportunities; our ability to manage growth with respect to our operations and new business opportunities; our ability to secure intellectual property rights over our proprietary products or enter into license agreements to secure the legal use of certain patents and intellectual property; our ability to avoid infringement of intellectual property rights; and our ability to be successful in new markets; These our actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievements described in or implied by such statements. Actual results may differ materially from expected results described in our forward-looking likely impact, and the accuracy and completeness of the publicly available information with respect to the factors upon which our business strategy is based or the success of our business. Forward-looking or the times by which, our performance or results may be achieved. Forward-looking statements are based on information available at the time those statements are made and management's belief as of that time with respect to future event

Risk Factors

Risk Factors Risk Factors Summary Our business is subject to numerous risks described in the section titled "Risk Factors", which you should read in its entirety starting from page 1 and elsewhere in this Annual Report. 1 Risks Related to Our Business and Industry We have a history of operating losses and may not achieve or sustain profitability in the future. We will require substantial additional financing to achieve our goals, and a failure to obtain this necessary capital when needed could force us to delay, limit, reduce or terminate our product development or commercialization efforts. Our operating results may fluctuate, as we have created a new class of products for which demand is unknown, which makes our results difficult to predict and could cause our results to fall short of our expectations. Fluctuations in the prices of raw materials can increase the cost of our products, impact our ability to meet production commitments, and may adversely affect our results of operations. Our customers have a history of delaying orders which may adversely affect our revenues and income. There is substantial doubt about our ability to continue as a going concern. The COVID-19 pandemic has had, and may continue to have, a material adverse effect on our financial condition and results of operations. We face risks related to the ongoing Russian invasion of Ukraine and any other conflicts that may arise on a global or regional scale which could adversely affect our business and results of operations. If the market for our gels does not develop or become sustainable, expands more slowly than we expect, or becomes saturated, our revenues may fail to materialize, and our financial condition and results of operations could be materially and adversely affected. Our success depends on our ability to obtain market acceptance for our products and services. The loss of the services of our key personnel would negatively affect our business. Risk Relate

View Full Filing

View this 20-F filing on SEC EDGAR